时间：2026-03-23 16:56:21 来源：网络整理编辑：時尚
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
TopicsHealth
Richard Branson 'thought he was going to die' in bike accident2026-03-23 16:51
Huawei caught using stock images to promote smartphone's camera2026-03-23 16:36
The Emoji Challenge has inspired a fierce group chat competition2026-03-23 16:07
Jaunt turns old gas cars into electric vehicles for road adventures2026-03-23 15:54
U.S. government issues warning on McDonald's recalled wearable devices2026-03-23 15:47
The 8 best funny horror movies for the easily spooked2026-03-23 15:15
Review: Lunarly, the self2026-03-23 14:57
Oprah made Tim Cook cry at the Apple TV+ event2026-03-23 14:57
Olympic security asks female Iranian fan to drop protest sign2026-03-23 14:30
Robert Downey Jr. sparks 'Avengers' battle over who has the best 'stache2026-03-23 14:12
Hiddleswift finally followed each other on Instagram after 3 excruciating days2026-03-23 16:54
Chunky baby seal born in Japan. Look at him, love him.2026-03-23 16:09
Hallmark drops Lori Loughlin after college admissions scandal2026-03-23 16:01
'Us' review roundup: Scarier than 'Get Out,' led by Lupita Nyong'o2026-03-23 15:54
U.S. government issues warning on McDonald's recalled wearable devices2026-03-23 15:53
Why is Fox News so quiet about Jeanine Pirro's anti2026-03-23 15:45
The viral 'Trashtag Challenge' encourages people to clean up litter2026-03-23 15:39
Hallmark drops Lori Loughlin after college admissions scandal2026-03-23 15:37
Darth Vader is back. Why do we still care?2026-03-23 14:22
Jaunt turns old gas cars into electric vehicles for road adventures2026-03-23 14:20
